Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naldemedine for Opioid-induced Bowel Dysfunction
NCT06334198Phase 2Recruiting
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naldemedine in opioid-induced bowel dysfunction (OIBD). Started Mar 2024; status: recruiting.
02
Drugs
naldemedine
03
Conditions
opioid-induced bowel dysfunction (OIBD)
Beyond the preview
Go deeper on NCT06334198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06334198.